Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļZTS
āļāļ·āđāļāļāļĢāļīāļĐāļąāļZoetis Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļFeb 01, 2013
āļāļĩāļāļĩāđāļPeck (Kristin C)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ13800
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļFeb 01
āļāļĩāđāļāļĒāļđāđ10 Sylvan Way
āđāļĄāļ·āļāļPARSIPPANY
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ07054
āđāļāļĢāļĻāļąāļāļāđ19738227000
āđāļ§āđāļāđāļāļāđhttps://www.zoetis.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļZTS
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļFeb 01, 2013
āļāļĩāļāļĩāđāļPeck (Kristin C)
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
Ms. Louise M. Parent
Independent Director
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Mr. Frank A. D'Amelio
Independent Director
Mr. Sanjay Khosla
Independent Director
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Ms. Vanessa Broadhurst
Independent Director
Mr. Jamie Brannan
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
Mr. Keith Sarbaugh
Executive Vice President, Chief Digital and Technology Officer
Executive Vice President, Chief Digital and Technology Officer
Dr. Robert J. (Rob) Polzer, Ph.D.
Dr. Robert J. (Rob) Polzer, Ph.D.
Executive Vice President, President - Research and Development
Executive Vice President, President - Research and Development
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
Ms. Louise M. Parent
Independent Director
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Mr. Frank A. D'Amelio
Independent Director
Mr. Sanjay Khosla
Independent Director
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices